Aurora Spine Corporation

TSX VENTURE : ASG


Aurora Spine Corporation

December 19, 2013 09:01 ET

Aurora Spine Corporation: First Surgical Implant of ZIP MIS Interspinous Implant Performed in Germany

CARLSBAD, CALIFORNIA--(Marketwired - Dec. 19, 2013) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first surgical implant of the company's ZIP ULTRA™ Minimally Invasive Interspinous Implant in Germany. The surgery was performed at Kliniken des landkreises lorrach in Southwest Germany by Professor Pfieffer.

This surgery marks the expansion of the use of Aurora's MIS device into another country, thereby strengthening the growth of Aurora Spine worldwide. The company works to continuously innovate in order to provide surgeons with the efficiency, simplicity and security they desire during minimally invasive procedures.

"It has been our honor to work with Dr. Pfeiffer, Dr. Rozeik, and their teams. Through our collaboration, the first ZIP ULTRA MIS Interspinous Fusion system surgeries in Germany have been completed," stated Laszlo Garamszegi, Chief Technical Officer of the company. "We are excited to continue to extend the reach of the ZIP MIS Interspinous Fusion system beyond previous locations. We believe that this new fusion technology will allow patients to rapidly resume their normal routines."

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of Aurora Spine's products and the introduction, potential and use of its products in new markets. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Contact Information

  • Aurora Spine Corporation
    Trent Northcutt
    President and Chief Executive Officer
    (760) 424-2004

    Aurora Spine Corporation
    Eric Fronk
    Chief Financial Officer
    (760) 424-2004